Atlas Trials

NeuroRx, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NeuroRx, Inc.

RecordFirmDate
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial (NCT07227103)NeuroRx, Inc.2026-09-01
NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis (NCT06128213)NeuroRx, Inc.2024-03-31
NRX-101 for Bipolar Depression With Subacute Suicidal Ideation (NCT03395392)NeuroRx, Inc.2022-05-12
Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. (NCT04990466)NeuroRx, Inc.2021-09-30
NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation (NCT03396068)NeuroRx, Inc.2019-12-01
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression (NCT03396601)NeuroRx, Inc.2019-06-25
NRX101 Glx Biomarker Validation Study (NCT03402152)NeuroRx, Inc.2018-11-01
Sequential Therapy for the Treatment of Severe Bipolar Depression. (NCT02974010)NeuroRx, Inc.2018-01-15

Track NeuroRx, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.